The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 08, 2018
Filed:
Dec. 21, 2015
Applicant:
Imaxio, Paris, FR;
Inventors:
Judith Del Campo Ascarateil, Taverny, FR;
Fergal Hill, Lyons, FR;
Assignee:
OSIVAX SAS, , FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); C07K 14/005 (2006.01); A61K 47/48 (2006.01); A61K 39/145 (2006.01); C07K 14/11 (2006.01); C07K 14/435 (2006.01); C07K 14/445 (2006.01); C12N 7/00 (2006.01); A61K 47/64 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 39/145 (2013.01); A61K 47/646 (2017.08); C07K 14/005 (2013.01); C07K 14/11 (2013.01); C07K 14/435 (2013.01); C07K 14/445 (2013.01); C12N 7/00 (2013.01); A61K 2039/525 (2013.01); A61K 2039/53 (2013.01); C07K 2319/00 (2013.01); C07K 2319/735 (2013.01); C12N 2760/16034 (2013.01); C12N 2760/16134 (2013.01);
Abstract
The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.